Vision Loss Impact on Navigation in Virtual Reality
Conditions: Stroke, Ischemic; Quadrantanopia; Hemianopsia, Homonymous; Hemianopia, Homonymous; Hemianopia; Hemianopsia; Occipital Lobe Infarct; Visual Field Defect, Peripheral; Vision Loss Partial; Quadrantanopsia; Stroke Hemorrhagic Intervention: Other: Virtual Reality Driving Task Sponsors: University of Rochester; Rochester Institute of Technology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Early Digi-physical Support During Breastfeeding Initiation - a Single-blind Randomized Controlled Trial
Conditions: Breastfeeding; Self Efficacy; Breastfeeding Duration; Depression Intervention: Other: Digi-physical breastfeeding support Sponsor: Region Stockholm Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Increasing access to CBT for psychosis patients: study protocol for a randomised controlled trial evaluating brief, targeted CBT for distressing voices delivered by assistant psychologists (GiVE3)
This study will investigate the clinical and cost-effectiveness of the GiVE intervention when delivered by assistant psychologists following a brief training.MethodsThis study is a pragmatic, two-arm, parallel group, superiority RCT comparing the GiVE intervention (delivered by assistant psychologists) and treatment as usual to treatment as usual alone, recruiting across three sites, using 1:1 allocation and blind post-treatment and follow-up assessments. A nested qualitative study will develop a model for implementation.DiscussionIf the GiVE intervention is found to be effective when delivered by assistant psychologists, ...
Source: Trials - September 15, 2023 Category: Research Source Type: clinical trials
RCT on Red Light Treatment for Myopic Minors' Retinal Impact
Condition: Red Laser Light-Induced Retinopathy of Both Eyes (Diagnosis) Intervention: Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
CRISPR/Cas13-mediated RNA Targeting Therapy for the Treatment of nAMD Investigator-Initiated Trial (SIGHT-I)
Condition: Neovascular Age-related Macular Degeneration(nAMD) Intervention: Genetic: HG202 Sponsors: HuidaGene Therapeutics Co., Ltd.; Tianjin Medical University Eye Hospital; Eye & ENT Hospital of Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials
